SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Latus Bio Announces Publication of Huntington’s Disease Model Study

A Nature Communications study presents a predictive computational model of Huntington’s disease built on human data, alongside validating preclinical data supporting LTS-201 as a potential disease-modifying therapy.

SquawkNews Desk

Related stories

Nasdaq Falls as Alphabet Faces Record Loss Amid AI Spending Woes U.S. stocks are lower, with the Dow down 0.35%. Alphabet is set for a record loss amid concerns over AI spending. M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC High Quality Food reports Q3 2026 revenue of €4.6 million M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC High Quality Food Q3 Revenue Rises 4% to EUR 4.67 Million M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC CPV Secures $825 Million Financing for Two U.S. Power Plants OPC Energy's U.S. subsidiary CPV secured $825 million in financing for the Shore and Maryland power plants. The structure consolidates existing project-level debt under a single fa M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC X-FAB Expects Q4 Revenue of $205-215 Million X-FAB expects fourth-quarter revenue within a range of $205-215 million. M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC Pilgrim’s Pride Q3 Profit Falls M impact | EQUITY | Oct 29, 2026, 04:42 PM UTC